This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX USA Congress
Life Science Executive Partnering
Congress Sept 16-17, Forums Sept 15, 2025Thomas Michael Menino Convention & Exhibition Center, Boston, USA

Nick Clarke
Chief Development Officer at NodThera
Speaker

Profile

Nick joined NodThera at the beginning of 2019 and is leading the development of NodThera drug candidates through preclinical and clinical testing.Prior to joining NodThera, Nick spent over 21 years at Pfizer working in the UK and US across a range of disease areas. Nick has a long history of leading successful projects in both the preclinical and clinical phase of drug development across of a variety of therapeutic areas including allergy, respiratory, inflammation and rare disease. Under his leadership these projects have progressed through early preclinical experimentation, candidate selection and initial clinical studies in volunteers through to Ph2a and Ph2b studies in patients.Nick received his Bachelor of Science in Pharmacology from the University of Portsmouth and his Ph.D. in Anatomical Neuropharmacology from the University of Oxford.

Agenda Sessions

  • Utilising Oral Small Molecule NLRP3 Inflammasome Inhibitors to Address Unmet Needs of People Living with Obesity

    2:30pm